Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | January 08, 2025 |
| PDB ID | UniProt ID ▲ | Title | Descriptor |
|---|---|---|---|
| 7SCK | Q16394 | Cryo-EM structure of the human Exostosin-1 and Exostosin-2 heterodimer in complex with a 7-sugar oligosaccharide acceptor analog | |
| 7UQX | Q16394 | Cryo-EM structure of the human Exostosin-1 and Exostosin-2 heterodimer in complex with UDP-GlcNAc | |
| 7UQY | Q16394 | Cryo-EM structure of the human Exostosin-1 and Exostosin-2 heterodimer in complex with UDP-GlcA | |
| 5TCO | Q16539 | Human p38 MAP Kinase in Complex with Dibenzosuberone Compound 1 | |
| 6HWU | Q16539 | Crystal structure of p38alpha in complex with a photoswitchable 2-Azothiazol-based Inhibitor (compound 2) | |
| 6HWT | Q16539 | Crystal structure of p38alpha in complex with a reduced photoswitchable 2-Azothiazol-based Inhibitor (compound 31) | |
| 6QYX | Q16539 | p38(alpha) MAP kinase with the activation loop of ERK2 | |
| 6HWV | Q16539 | Crystal structure of p38alpha in complex with a photoswitchable 2-Azoimidazol-based Inhibitor (compound 3) | |
| 1ZYJ | Q16539 | Human P38 MAP Kinase in Complex with Inhibitor 1a | |
| 1ZZ2 | Q16539 | Two Classes of p38alpha MAP Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Divergent Binding Modes | |
| 2FSL | Q16539 | mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-A | |
| 2FSM | Q16539 | mitogen activated protein kinase p38alpha (D176A+F327S) activating mutant form-B | |
| 2FSO | Q16539 | mitogen activated protein kinase p38alpha (D176A) activating mutant | |
| 2FST | Q16539 | mitogen activated protein kinase p38alpha (D176A+F327L) activating mutant | |
| 2NPQ | Q16539 | A Novel Lipid Binding Site in the p38 alpha MAP Kinase | |
| 3GCP | Q16539 | Human P38 MAP Kinase in Complex with SB203580 | |
| 3GCQ | Q16539 | Human P38 MAP kinase in complex with RL45 | |
| 3GCS | Q16539 | Human P38 MAP kinase in complex with Sorafenib | |
| 3GCU | Q16539 | Human P38 MAP kinase in complex with RL48 | |
| 3GCV | Q16539 | Human P38 MAP Kinase in Complex with RL62 | |
| 3HEC | Q16539 | P38 in complex with Imatinib | |
| 3HUB | Q16539 | Human p38 MAP Kinase in Complex with Scios-469 | |
| 3HUC | Q16539 | Human p38 MAP Kinase in Complex with RL40 | |
| 3HV3 | Q16539 | Human p38 MAP Kinase in Complex with RL49 | |
| 3HV4 | Q16539 | Human p38 MAP Kinase in Complex with RL51 | |
| 3HV5 | Q16539 | Human p38 MAP Kinase in Complex with RL24 | |
| 3HV6 | Q16539 | Human p38 MAP Kinase in Complex with RL39 | |
| 3HV7 | Q16539 | Human p38 MAP Kinase in Complex with RL38 | |
| 3IW5 | Q16539 | Human p38 MAP Kinase in Complex with an Indole Derivative | |
| 3IW6 | Q16539 | Human p38 MAP Kinase in Complex with a Benzylpiperazin-Pyrrol | |
| 3IW7 | Q16539 | Human p38 MAP Kinase in Complex with an Imidazo-pyridine | |
| 3IW8 | Q16539 | Structure of Inactive Human p38 MAP Kinase in Complex with a Thiazole-Urea | |
| 3L8S | Q16539 | Human p38 MAP Kinase in Complex with CP-547632 | |
| 3LFA | Q16539 | Human p38 MAP Kinase in Complex with Dasatinib | |
| 3LFB | Q16539 | Human p38 MAP Kinase in Complex with RL98 | |
| 3LFC | Q16539 | Human p38 MAP Kinase in Complex with RL99 | |
| 3LFD | Q16539 | Human p38 MAP Kinase in Complex with RL113 | |
| 3LFE | Q16539 | Human p38 MAP Kinase in Complex with RL116 | |
| 3LFF | Q16539 | Human p38 MAP Kinase in Complex with RL166 | |
| 3MGY | Q16539 | Mutagenesis of p38 MAP Kinase eshtablishes key roles of Phe169 in function and structural dynamics and reveals a novel DFG-out state | |
| 3MH0 | Q16539 | Mutagenesis of p38 MAP Kinase eshtablishes key roles of Phe169 in function and structural dynamics and reveals a novel DFG-out state | |
| 3MH1 | Q16539 | Mutagenesis of p38 MAP kinase establishes key roles of Phe169 in function and structural dynamics and reveals a novel DFG-out state | |
| 3MH2 | Q16539 | Mutagenesis of p38 MAP kinase establishes key roles of Phe169 in function and structural dynamics and reveals a novel DFG-out state | |
| 3MH3 | Q16539 | Mutagenesis of p38 MAP kinase establishes key roles of Phe169 in function and structural dynamics and reveals a novel DFG-out state | |
| 3MPA | Q16539 | Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding | |
| 3O8P | Q16539 | Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding | |
| 3O8T | Q16539 | Conformational plasticity of p38 MAP kinase DFG-motif mutants in response to inhibitor binding | |
| 3O8U | Q16539 | Conformational plasticity of p38 MAP kinase DFG motif mutants in response to inhibitor binding | |
| 3OBJ | Q16539 | Conformational plasticity of p38 MAP kinase DFG mutants in response to inhibitor binding | |
| 3OD6 | Q16539 | Crystal structure of p38alpha Y323T active mutant |
